Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlant Impact Regulatory News (PIM)

  • There is currently no data for PIM

AGM Trading Update

15 Dec 2017 07:00

RNS Number : 4370Z
Plant Impact PLC
15 December 2017
 

15 December 2017

Plant Impact plc

 

("Plant Impact", the "Company" or together with its subsidiaries, the "Group")

AGM Trading Update

Plant Impact plc (AIM: PIM), which leads research and development in crop enhancement technology to create products that growers can rely on to increase the yield and quality of their crops, will hold its Annual General Meeting ("AGM") today at 12.00 noon at the Rothamsted Conference Centre in Harpenden.

Ahead of the AGM, the Group announces the following trading update for the year to date. This update follows the announcement made on 13 December 2017 when the Company informed the market of important developments with Bayer CropScience ("BCS") and announced that it was evaluating all potential strategic options and entering a formal sales process. 

Operational update

Good progress continues to be made in the R&D activities of the Company. Since the start of the new financial year on 1 August 2017, four new compounds have completed lab and glasshouse assays in our early stage research work ("Discovery") and progressed to the next development stage. All four compounds show significant early yield indications and these compounds are now scheduled for more extensive development stage trials. One of the new compounds showed particular potential in our S1 seed treatment project and the other three showed promise as part of the F1 foliar spray project. 

Discovery work in collaboration with Ghent University is progressing well, with trials demonstrating that novel Pyrabactin analogues can control the aperture of leaf stomata and thereby reduce water loss. This intervention to improve the efficiency of a plant's water use could increase yield in drought conditions. 

Later stage R&D work includes important new trials underway in Brazil of the full portfolio of four individually proven soybean crop enhancement products and projects. For the first time, the combined effect of the full portfolio on soybean yield will be tested, targeting an uplift of over 15% in total yield improvement. Separate trials of S1 and F1 project formulations are also underway in Brazil and Argentina.

In Brazil, as announced on 13 December 2017, BCS has informed the Group that it will not be able to conclude a new contractual arrangement for Veritas® distribution until Q1 2018 at the earliest and that it will defer the purchase of further Veritas® volumes. Please refer to the Formal Sale Process paragraph below for further details.

Notwithstanding this recent development, we are continuing to work with BCS in the field in Brazil, to build the Veritas® business. Campaign activity is underway for the 2017/18 soybean and drybean growing season. The expectations of both ourselves and BCS are for good grower adoption of the product. Additionally, following trials of Veritas® on cotton plants in Brazil 2016/17, BCS intends to launch a commercial campaign for selected customers in the Mato Grosso and Bahia regions in 2018, which is based on proven yield uplifts of around 5 -7%, consistent with those seen in soybean.

In the USA, following the first season of product sales of Fortalis®, relationships with a network of key regional and national distributors are developing well, with coverage of every soybean-growing State already agreed for the 2018 US growing season.

In Argentina we are gearing up for the launch of the first full season of Fortalis® sales as a Plant Impact branded product. Arrangements are being put in place with local partners to provide distribution capability across the key soybean growing regions.

New partnership and product launch in Brazil

We are today announcing a new partnership with Albaugh Brazil ("Albaugh"). This partnership is separate to, and has no impact on, our relationship with BCS in Brazil to distribute Veritas®. Under a new distribution agreement, Albaugh will exclusively commercialize certain other Plant Impact technologies as Albaugh branded products, which will be offered through its extensive dealer network in Brazil targeting growers in the primary soybean, corn, cotton and coffee growing regions. The partnership will begin with the launch and regional test marketing of Fortiori®, a new Albaugh branded product based on a Plant Impact formulation. Fortiori® resolves a significant issue for growers due to "in-tank" antagonism between glyphosate herbicides and foliar-applied manganese nutrients.

Appointment of Interim Chief Financial Officer

The Board is pleased to announce that Ib Jensen today joins the Company in the non-Board position of Interim Chief Financial Officer and Company Secretary. Mr Jensen is a senior finance professional who has worked in a number of businesses and industries over a 25 year career. For the past ten years he has held a number of roles with Syngenta, the agricultural chemical multi-national, including four years from 2012 to 2016 based in Brazil as the CFO of its Latin American business. 

As previously announced on 6 October 2017, Richard Amos, the current CFO will be resigning from the Board at the conclusion of today's AGM. He will remain employed by the business until 9 February 2018 to ensure an efficient handover to Mr Jensen.

Formal Sale Process

The Company announced on 13 December 2017 that it had decided to investigate all potential strategic options for the business, including refinancing, potential divestment of selected assets or the sale of the Company. The Board has appointed Peel Hunt LLP as its financial adviser for this process, which includes the Company entering a formal sale process as referred to in the City Code on Takeovers and Mergers (the "Takeover Code").

As detailed in the 13 December 2017 announcement, the Company's reason for investigating all options is a consequence of BCS's decision to defer the purchase of further Veritas® volumes, which will have a material adverse effect on the Company's financial performance and on its cash resources.

Full details can be found in the 13 December 2017 announcement. At this time, there is no further update to that statement. 

 

For further information please contact:

Plant Impact plc

David Jones, Chairman

John Brubaker, Chief Executive Officer

Ailish Tracy, Global Communications Manager

 

 

Tel: +44 (0) 1582 465 540

 

Peel Hunt - Financial Adviser, Nominated Adviser and Broker

Adrian Trimmings

Michael Nicholson

George Sellar

Nicole McDougall

 

Buchanan - Financial PR

Mark Court

Sophie Wills

Jamie Hooper

Tel: +44 (0) 207 418 8900

 

 

 

Tel: +44 (0) 207 466 5000

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLFFSFFILSLID
Date   Source Headline
31st Jul 20139:28 amRNSTotal Voting Rights
23rd Jul 20137:00 amRNSCompletion of Share Subscription
18th Jul 20137:00 amRNSBrazil Commercial Agreement
14th Jun 20139:00 amRNSBrazil Soya Field Trial Results
3rd Jun 20137:00 amRNSRepayment of Development Loan & Trading Update
17th May 20132:28 pmRNSHolding(s) in Company
22nd Apr 201311:07 amRNSHolding(s) in Company
22nd Apr 20137:00 amRNSInterim Results
7th Mar 20135:16 pmRNSHolding(s) in Company
25th Feb 201311:42 amRNSAccounting Reference Date Change - Replacement
25th Feb 20137:00 amRNSAccounting Reference Date Change
7th Feb 20139:26 amRNSTotal Voting Rights
7th Jan 20137:00 amRNSResult of Open Offer
4th Jan 20137:00 amRNSDirector/PDMR Shareholding
31st Dec 20127:00 amRNSTotal Voting Rights
24th Dec 20127:00 amRNSDirectorate Change
19th Dec 20127:00 amRNSHalf Yearly Report
18th Dec 20128:15 amRNSHolding(s) in Company
7th Dec 20127:00 amRNSCompletion of Placing & announcement of Open Offer
18th Oct 20122:13 pmRNSBrazil Business Launch
17th Sep 20129:29 amRNSHolding(s) in Company
14th Sep 20129:40 amRNSResult of AGM
10th Sep 201210:18 amRNSDirector's Dealing
5th Sep 201211:08 amRNSHolding(s) in Company
3rd Sep 20121:01 pmRNSChange of Registered Office
17th Aug 201211:09 amRNSNotice of AGM
16th Jul 20127:00 amRNSFinal Results
3rd Jul 201210:00 amRNSResearch Cooperation and Relocation of Head Office
28th Jun 20125:26 pmRNSGrant and Cancellation of Share Options
28th Jun 20125:23 pmRNSFurther Details on Chief Executive Officer
5th Apr 201210:38 amRNSUS EPA BugOil Registration and Trading Update
8th Mar 20123:12 pmRNSExercise of Options
22nd Feb 20128:09 amRNSUS EPA Proposed BugOil Registration Decision
20th Feb 20127:01 amRNSDirectorate Change
20th Feb 20127:00 amRNSAmendment of License & Development Loan Agreements
13th Feb 201211:26 amRNSHolding(s) in Company
1st Feb 20127:35 amRNSPress Speculation
15th Dec 20117:00 amRNSHalf Yearly Report
7th Oct 20117:49 amRNSChange of Adviser
6th Oct 20112:45 pmRNSIssue of Equity
26th Aug 20111:30 pmRNSGrant of share options
26th Aug 201110:40 amRNSResult of AGM
16th Aug 20112:40 pmRNSHolding(s) in Company
16th Aug 20118:15 amRNSDirector/PDMR Shareholding
9th Aug 20117:00 amRNSAppointment of new CEO
4th Aug 20113:30 pmRNSNotice of AGM
4th Jul 201111:30 amRNSPreliminary Results - replacement
4th Jul 20117:00 amRNSHalf Yearly Report
8th Jun 20117:00 amRNSCanadian Distribution Agreement
2nd Jun 20111:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.